DK1471143T3 - Fremgangsmåde og kit til vurdering af udbrud af rheumatoid arthritis - Google Patents

Fremgangsmåde og kit til vurdering af udbrud af rheumatoid arthritis

Info

Publication number
DK1471143T3
DK1471143T3 DK03700501T DK03700501T DK1471143T3 DK 1471143 T3 DK1471143 T3 DK 1471143T3 DK 03700501 T DK03700501 T DK 03700501T DK 03700501 T DK03700501 T DK 03700501T DK 1471143 T3 DK1471143 T3 DK 1471143T3
Authority
DK
Denmark
Prior art keywords
rheumatoid arthritis
protein
kit
outbreaks
onset
Prior art date
Application number
DK03700501T
Other languages
English (en)
Inventor
Shunichi Shiozawa
Koichiro Komai
Mikiko Nakatsukasa
Original Assignee
Shunichi Shiozawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shunichi Shiozawa filed Critical Shunichi Shiozawa
Application granted granted Critical
Publication of DK1471143T3 publication Critical patent/DK1471143T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
DK03700501T 2002-01-11 2003-01-08 Fremgangsmåde og kit til vurdering af udbrud af rheumatoid arthritis DK1471143T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002005326A JP4242590B2 (ja) 2002-01-11 2002-01-11 慢性関節リウマチの疾患感受性遺伝子、及びその利用
PCT/JP2003/000089 WO2003060126A1 (fr) 2002-01-11 2003-01-08 Gene sensible a la polyarthrite rhumatoide, sa proteine, procede et kit permettant d'evaluer l'apparition de la maladie a travers ce gene, ainsi que procede et medicaments pour le traitement de ladite maladie

Publications (1)

Publication Number Publication Date
DK1471143T3 true DK1471143T3 (da) 2008-06-16

Family

ID=19191091

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03700501T DK1471143T3 (da) 2002-01-11 2003-01-08 Fremgangsmåde og kit til vurdering af udbrud af rheumatoid arthritis

Country Status (11)

Country Link
US (1) US7615341B2 (da)
EP (1) EP1471143B1 (da)
JP (1) JP4242590B2 (da)
KR (1) KR100976005B1 (da)
AT (1) ATE387460T1 (da)
CA (1) CA2473218C (da)
DE (1) DE60319342T2 (da)
DK (1) DK1471143T3 (da)
ES (1) ES2301778T3 (da)
PT (1) PT1471143E (da)
WO (1) WO2003060126A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4657757B2 (ja) * 2005-02-23 2011-03-23 株式会社膠原病研究所 肺高血圧症発症関連遺伝子を用いた肺高血圧症の診断および治療
JP2006325528A (ja) * 2005-05-27 2006-12-07 Institute For Rheumatic Diseases Co Ltd 糖尿病性網膜症の診断および予防
JP4657857B2 (ja) * 2005-08-25 2011-03-23 株式会社膠原病研究所 メタボリックシンドロームの診断および予防
JP2009136229A (ja) * 2007-12-07 2009-06-25 Institute For Rheumatic Diseases Co Ltd 自己免疫疾患モデル細胞又は自己免疫疾患モデル動物の作製方法、並びに自己免疫疾患の診断方法
JP2018518992A (ja) * 2015-06-24 2018-07-19 オックスフォード バイオダイナミックス リミテッド 染色体相互作用の部位を用いた検出法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585464A (en) 1993-02-19 1996-12-17 Theratech, Inc. Recombinant antigen for diagnosing rheumatoid arthritis
US5814464A (en) 1994-10-07 1998-09-29 Regeneron Pharma Nucleic acids encoding TIE-2 ligand-2
AU715621B2 (en) * 1995-04-06 2000-02-03 Regeneron Pharmaceuticals, Inc. TIE-2 ligands, methods of making and uses thereof
CA2289961C (en) 1997-05-15 2009-03-31 Shunichi Shiozawa A gene causative of rheumatoid arthritis, method for diagnosing rheumatoid arthritis, and method for identifying causative factors of rheumatoid arthritis
BR9912053A (pt) 1998-07-13 2001-04-03 Univ Texas Processos de tratamento de câncer utilizando conjugados terapêuticos que se ligam a aminofosfolipìdios
WO2000011164A1 (en) * 1998-08-20 2000-03-02 Incyte Pharmaceuticals, Inc. Human angiopoietin-3
EP1164190B1 (en) * 1999-03-20 2011-06-29 Shunichi Shiozawa Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis
CA2372053C (en) * 1999-04-28 2008-09-02 Board Of Regents, The University Of Texas System Compositions and methods for cancer treatment by selectively inhibiting vegf
DE10100586C1 (de) * 2001-01-09 2002-04-11 Ribopharma Ag Verfahren zur Hemmung der Expression eines Ziegens
JP3596433B2 (ja) * 2000-06-29 2004-12-02 株式会社デンソー 車載用電子制御装置
AU1092602A (en) 2000-10-24 2002-05-06 New Ind Res Organization Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detectingthem and therapeutic method and remedies for rheumatoid arthritis

Also Published As

Publication number Publication date
US20050176004A1 (en) 2005-08-11
CA2473218C (en) 2011-07-19
DE60319342D1 (de) 2008-04-10
EP1471143A1 (en) 2004-10-27
ATE387460T1 (de) 2008-03-15
PT1471143E (pt) 2008-05-20
EP1471143A4 (en) 2005-09-14
AU2003201847A1 (en) 2003-07-30
KR20040077715A (ko) 2004-09-06
ES2301778T3 (es) 2008-07-01
WO2003060126A1 (fr) 2003-07-24
JP4242590B2 (ja) 2009-03-25
US7615341B2 (en) 2009-11-10
CA2473218A1 (en) 2003-07-24
EP1471143B1 (en) 2008-02-27
DE60319342T2 (de) 2009-03-19
KR100976005B1 (ko) 2010-08-17
JP2003204790A (ja) 2003-07-22

Similar Documents

Publication Publication Date Title
EA200600869A1 (ru) Антитела, связывающие рецептор интерлейкина-4
DK1679319T3 (da) Fremgangsmåde til forebyggelse og behandling af Alzheimers sygdom (AD)
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
IN2015KN00290A (da)
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
DK1088098T3 (da) Lægemiddel til behandling af HIV-inficerede pattedyr
DK0510079T3 (da) Proteiner, der er produceret af humane lymfocytter, DNA-sekvenser, der koder for disse proteiner, og farmaceutiske og biolo
IL207877A0 (en) Alzheimer's disease treatment method
DK0784703T3 (da) Lamininkæder: Diagnostisk og terapeutisk anvendelse
DK1515752T3 (da) ACE2-aktivering til behandling af hjerte-, lunge- og nyresygdomme og hypertension
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
CY1105380T1 (el) Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων
EP0572478A4 (en) A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases
DK1471143T3 (da) Fremgangsmåde og kit til vurdering af udbrud af rheumatoid arthritis
EA200000146A1 (ru) Лиганды, включая антитела, проявляющие реактивность в отношении эндокринных клеток
DK1536006T3 (da) Cancerantigener og anvendelse deraf
NZ330744A (en) A long qt syndrome gene which encodes kvlqt1 and its association with mink
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
ATE534902T1 (de) Replikationsproteinn ciz1
ATE435657T1 (de) Therapeutische zubereitung von hochreinem fviia und verfahren zu dessen gewinnung
DE50303798D1 (de) Vorrichtung, um in einem Zielgebiet eines menschlichen oder tierischen Körpers einen künstlichen isolierten Kreislauf zu etablieren
ATE490979T1 (de) Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
DE69734890D1 (de) Rdgb-proteine
DK0973887T3 (da) Porcin leptin-protein, nukleinsyresekvenser, som koder herfor, og anvendelser heraf